Fred Gebhart
Intranasal neurostimulation yields positive results for dry eye disease
The first portable, external neurostimulator to be approved in eye care stimulates endogenous tear production without physical irritation. The device can dramatically reduce symptoms and may enable patients to stop use of some or all tear substitutes or medications, noted John Sheppard, MD, MMSc.
Consider family history of glaucoma before genetic testing, counseling
Though genetic testing can identify some types of glaucoma, risk assessment and counseling based on family history is more helpful for most patients than genetic testing, said Wallace L.M. Alward, MD.
How iPhone may replace slit lamp photos
In comparing conventional slit lamp photography with iPhone images, it was found the smartphone produces higher quality pictures and in a more economical way.
Why early cataract surgery may help glaucoma later
Cataract surgery not only can result in a reduction of IOP, it also provides benefits for future management of glaucoma.
Hypofractionated radiotherapy found efficacious for localized prostate cancer
A prospective multicenter trial in Canada has shown positive results with hypofractionated image-guided radiotherapy (H-IGRT) using widely available standard linear accelerators.
Analysis may explain exercise-prostate cancer progression link
A recent study may have found the genetic mechanism behind the potential association between vigorous exercise and a reduced risk of prostate cancer progression and prostate cancer-specific mortality in men with localized disease.
Robotic laparoscopic radical prostatectomy found viable in obese men
Obesity should not preclude a patient from undergoing robot-assisted laparoscopic prostatectomy (RALP), but these men may require more time for the procedure.
Adrenalectomies on the rise in high-volume centers
Higher-volume centers tend to treat adrenalectomy patients who are younger, have a shorter length of stay, and are less likely to die in the hospital when compared to patients treated at lower-volume centers. Researchers found that very low-volume centers treat patients who are older, more likely to be female, and covered by Medicaid or uninsured.
Data support American Urological Association guideline on bladder tumor re-resection
A 4-year retrospective study suggests that re-resection for all T1 bladder tumors, with and without muscle in the original specimen, can provide important prognostic information to guide treatment.
Adjuvant chemotherapy: Many cystectomy patients ineligible
New data from a single institution show that more patients with urothelial carcinoma are eligible for neoadjuvant chemotherapy before radical cystectomy than for adjuvant chemo following surgery.

Poll